CA - Acerus Pharmaceuticals CFO resigns effective November 20 2022
-
Acerus Pharmaceuticals ( OTCQB:ASPCF ) CFO Robert Motz to resign from the company effective November 20, 2022.
-
The company has begun a process to search for a new CFO and will provide an update at a future date.
-
“I would like to thank Bob for his contributions over the past four years.He has been a key contributor to our success, and we wish him the very best in the next phase of his career.” said Edward Gudaitis, President and Chief Executive Officer
For further details see:
Acerus Pharmaceuticals CFO resigns effective November 20, 2022